Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective

British Medical Journal

Volumn 305, Issue 6867, 1992, Pages 1457-1460

  Gustafsson, C ^a   Asplund, K ^a   Britton, M ^a   Norrving, B ^a   Olsson, B ^a   Marke, L A ^a  

^a Mariestad Hospital ^*  (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT;

AGE; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; COST EFFECTIVENESS ANALYSIS; HEART ATRIUM FIBRILLATION; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROPHYLAXIS; RISK ASSESSMENT; STROKE; SWEDEN;

EID: 0026463723     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.305.6867.1457     Document Type: Article

References (15)

1. Wolf, P.A.; Abbott, R.D.; Kannel, W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham study Stroke 1991 10.1161/01.STR.22.8.983 22 983
2. Petersen 1' Bovsen, G. Lancet; Placebocontrolled, randomised, trial of warfarin and aspirin for prevention of thrombo-embolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study 1989 i: 175
3. Conollv, S.J.; Laupacis, A.; Gent, I.M.; Roberts, R.S.; Cairns, J.A.; Joyner C for the CAFA Study Coinvestigators. Canadian atrial fibrillation (CAFA) study. JAw71 Coll Cardiol 1991 18 349
4. Cairns, J.A.; Conollv, S.J. Non-rheumatic atrial fibrillation. Risk of stroke and role of antithrombotic therapy Circalation 1991 10.1161/01.CIR.84.2.469 84 469
5. Landahl, S.; Svanborg, A.; Astrand, K. Heart solume and the prevalence of certain common cardiovascular disorders at age 70 and 75 1984 5 326
6. Albers, G.W.; Atwood, J.E.; Hirsh, J.; Sherman, D.G.; Hughes, R.A.; Conolly, S.J. Stroke prevention in non-valvular atrial fibrillation Attn Intert Med 1991 115 727
7. Kutner, I.M.; Nixon, G.; Silverstone, F. Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation Arch Itttern Aled 1991 151 1950
8. Landefeld, C.S.; Goldman, L. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy AmJMed 1989 87 144
9. Lundstrom, T.; Ryde'n, L. Haemorrhagic and thrombotic complications in patients with atrial fibrillation on anticoagulant prophylaxis J Int Med 1989 10.1111/j.1365-2796.1989.tb00053.x 225 137
10. Carlsson, A.; Gustafsson, C. Blodningskomplikationer till antikoagulantiabehandling. Abstract vid workshop om formaksflimmer Ldkemedelsverket 1992 11 21
11. Wintzen, A.R.; de Jonge, H.; Loegliger, E.A.; Bots, G.T.A.M. The risk of intracerebral hemorrhage during oral anticoagulant treatment: a population study Ant Neurol 1984 10.1002/ana.410160505 16 553
12. Terent, A. Kostnader for stroke vard
13. Persson, U.; Silverberg, R.; Lindgren, B.; Norrving, B.; Jadback, G.; Johansson, B. Direct costs of stroke for a Swedish population Ilnt J Technol Assess Health Care 1990 10.1017/S0266462300008989 6 125
14. Isard, P.A.; Forbes, J.F. The cost of stroke to the National Health Service in Scotland Cerebrovasc Dis 1992 10.1159/000108988 2 47
15. Lancaster, T.R.; Singer, D.E.; Sheehan, M.A.; Oertel, L.B.; Maraventano, S.W.; Hughes, R.A. The impact of long-term warfarin therapy on quality of life Arch Interni Med 1991 10.1001/archinte.1991.00400100032005 151 1944